A single-session intervention for reducing suicidal thoughts and behaviors
Randomized controlled trial of a single-session mechanism-focused intervention for suicidal thoughts and behaviors
This study is testing a quick, one-time treatment to help people who are struggling with suicidal thoughts by addressing feelings of hopelessness and loneliness, making it easier for those who might not go to regular therapy sessions to get the support they need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10998020 on NIH RePORTER |
What this research studies
This research investigates a brief, single-session intervention aimed at addressing suicidal thoughts and behaviors (STBs). It focuses on understanding and targeting the underlying mechanisms that contribute to these thoughts, such as feelings of hopelessness and social disconnection. By simplifying the treatment process, the study aims to make effective mental health care more accessible to individuals who may not attend multiple therapy sessions. Participants will receive a focused intervention designed to reduce their suicidal ideation and improve their overall mental health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing suicidal thoughts or behaviors who may struggle to access traditional mental health treatments.
Not a fit: Patients who do not experience suicidal thoughts or behaviors are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, this research could provide a more accessible and effective treatment option for individuals experiencing suicidal thoughts and behaviors.
How similar studies have performed: Previous research has shown that brief interventions can effectively reduce suicidal behaviors, suggesting that this approach may also yield positive results.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Fruhbauerova, Martina — University of Kentucky
- Study coordinator: Fruhbauerova, Martina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.